Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2014', provides an overview of the Laboratorios Del Dr. Esteve S.A.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Del Dr. Esteve S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Laboratorios Del Dr. Esteve S.A. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Laboratorios Del Dr. Esteve S.A.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Laboratorios Del Dr. Esteve S.A.'s pipeline products Reasons to buy - Evaluate Laboratorios Del Dr. Esteve S.A.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Laboratorios Del Dr. Esteve S.A. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Laboratorios Del Dr. Esteve S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Laboratorios Del Dr. Esteve S.A. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios Del Dr. Esteve S.A. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Laboratorios Del Dr. Esteve S.A. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Laboratorios Del Dr. Esteve S.A. Snapshot 5 Laboratorios Del Dr. Esteve S.A. Overview 5 Key Information 5 Key Facts 5 Laboratorios Del Dr. Esteve S.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Laboratorios Del Dr. Esteve S.A. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Laboratorios Del Dr. Esteve S.A. - Pipeline Products Glance 11 Laboratorios Del Dr. Esteve S.A. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 Laboratorios Del Dr. Esteve S.A. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Laboratorios Del Dr. Esteve S.A. - Drug Profiles 14 (celecoxib + tramadol hydrochloride) 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 E-52862 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Vaccine for HIV 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Gene Therapy for Sanfilippo A Syndrome 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Laboratorios Del Dr. Esteve S.A. - Pipeline Analysis 20 Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Target 20 Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Route of Administration 21 Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Molecule Type 22 Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Mechanism of Action 23 Laboratorios Del Dr. Esteve S.A. - Recent Pipeline Updates 24 Laboratorios Del Dr. Esteve S.A. - Dormant Projects 25 Laboratorios Del Dr. Esteve S.A. - Company Statement 26 Laboratorios Del Dr. Esteve S.A. - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Laboratorios Del Dr. Esteve S.A. - Key Manufacturing Facilities 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30
List of Tables Laboratorios Del Dr. Esteve S.A., Key Information 5 Laboratorios Del Dr. Esteve S.A., Key Facts 5 Laboratorios Del Dr. Esteve S.A. - Pipeline by Indication, 2014 7 Laboratorios Del Dr. Esteve S.A. - Pipeline by Stage of Development, 2014 8 Laboratorios Del Dr. Esteve S.A. - Monotherapy Products in Pipeline, 2014 9 Laboratorios Del Dr. Esteve S.A. - Combination Treatment Modalities in Pipeline, 2014 10 Laboratorios Del Dr. Esteve S.A. - Phase II, 2014 11 Laboratorios Del Dr. Esteve S.A. - Phase I, 2014 12 Laboratorios Del Dr. Esteve S.A. - Preclinical, 2014 13 Laboratorios Del Dr. Esteve S.A. - Pipeline by Target, 2014 20 Laboratorios Del Dr. Esteve S.A. - Pipeline by Route of Administration, 2014 21 Laboratorios Del Dr. Esteve S.A. - Pipeline by Molecule Type, 2014 22 Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Mechanism of Action, 2014 23 Laboratorios Del Dr. Esteve S.A. - Recent Pipeline Updates, 2014 24 Laboratorios Del Dr. Esteve S.A. - Dormant Developmental Projects,2014 25 Laboratorios Del Dr. Esteve S.A., Subsidiaries 27 Laboratorios Del Dr. Esteve S.A., Key Manufacturing Facilities 28
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
